| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |